Evidence map›Paper›PMID 40680013›Full record

ArticlePloS one2025

The challenges of replication: A worked example of methods reproducibility using electronic health record data.

Richard Williams, Thomas Bolton, David Jenkins, Mehrdad A Mizani, Matthew Sperrin, Cathie Sudlow, Angela Wood, Adrian Heald, Niels Peek, CVD-COVID-UK/COVID-IMPACT Consortium

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Review
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Richard WilliamsDivision of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-0920-1103
Thomas BoltonBritish Heart Foundation Data Science Centre, Health Data Research UK, London, United Kingdom.
David JenkinsDivision of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Mehrdad A MizaniBritish Heart Foundation Data Science Centre, Health Data Research UK, London, United Kingdom.
Matthew SperrinDivision of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Cathie SudlowBritish Heart Foundation Data Science Centre, Health Data Research UK, London, United Kingdom.ORCID https://orcid.org/0000-0002-7725-7520
Angela WoodBritish Heart Foundation Data Science Centre, Health Data Research UK, London, United Kingdom.
Adrian HealdDepartment of Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford, United Kingdom.
Niels PeekDivision of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
CVD-COVID-UK/COVID-IMPACT Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe ability to reproduce the work of others is an essential part of the scientific disciplines. Replicating observational studies using electronic health record (EHR) data can be challenging due to complexities in data access, variations in EHR systems across institutions, and the potential for unaccounted confounding variables. Our aim is to identify the barriers to methods reproducibility for replication studies using EHR data.

methodsWe replicated a study that examined the risk of hospitalisation following a positive COVID-19 test in individuals with diabetes. Using EHR data from the NHS England's Secure Data Environment (SDE) covering the whole of England, UK (population 57m), we sought to replicate findings from the original study, which used data from Greater Manchester (a large urban region in the UK, population 2.9m). Both analyses were conducted in Trusted Research Environments (TREs) or SDEs, containing linked primary and secondary care data, however methods reproducibility was not straightforward. Differences between the environments that contributed to the difficulties were documented, categorized into themes, and converted into a list of recommendations for TRE/SDEs.

resultsSmall differences between the environments and the data sources led to several challenges in methods reproducibility. Our recommendations of TRE/SDEs should facilitate future replication studies. The recommendations include: a need for improved machine-readable metadata for EHR data; standardization of governance processes to facilitate federated analysis; mandating of code sharing; and for environments to have a support structure for data engineers and analysts. We also propose a new theme for research, "data reproducibility", as the ability to prepare, extract and clean data from a different database for a replication study.

conclusionEven with perfect code sharing, data reproducibility remains a challenge. Our recommendations have the potential to reduce the barriers to replication studies and therefore enhance the potential of observational studies using EHR data.

Indexed as

COVID-19Electronic Health RecordsEnglandHospitalizationHumansReproducibility of ResultsSARS-CoV-2

Identifiers

PMID40680013
PMCPMC12273930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.